United States Pharmaceuticals

Morphic Holding Inc (MORF)

Track

Ticker: MORF Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Morphic Holding Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 8 Jul 2024
Value US$4,046,353.67 | Price 186.25 | Shares 18,541 (+16.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-07-10 2024-07-08 PlS Planned sale
1.2
DeVaul William

General Counsel and Secretary

Officer
18,541 +16.8%
186.25
US$4,046,354 		18,541 +16.8% 186.25 US$4,046,354
2024-07-10 2024-07-08 PlS Planned sale
1.2
Tipirneni Praveen P.

President and CEO

Executive Director
92,224 +1.0%
366.51
US$1,268,465 		92,224 +1.0% 366.51 US$1,268,465
2024-07-10 2024-07-08 PlS Planned sale
1.2
SCHEGERIN MARC

CFO and COO

Officer
91,088 +46.6%
362.12
US$509,264 		91,088 +46.6% 362.12 US$509,264
2024-07-10 2024-07-08 PlS Planned sale
1.4
Farrell Robert E Jr

SVP Finance and CAO

Officer
30,272 -68.7%
55.80
US$1,689,178 		30,272 -68.7% 55.80 US$1,689,178
2024-07-10 2024-07-08 PlS Planned sale
1.6
Rogers Bruce

PRESIDENT

Officer
20,000 -11.8%
55.79
US$1,115,820 		20,000 -11.8% 55.79 US$1,115,820
2024-07-08 2024-07-08 PrS Proposed sale
1.2
Praveen R. Tipirneni

Officer

Officer
64,746
55.00
US$3,561,030 		64,746 55.00 US$3,561,030
2024-07-08 2024-07-08 PrS Proposed sale
1.6
Bruce Rogers

Officer

Officer
20,000
55.00
US$1,100,000 		20,000 55.00 US$1,100,000
2024-07-08 2024-07-08 PrS Proposed sale
1.2
William DeVaul

Officer

Officer
45,000
55.00
US$2,475,000 		45,000 55.00 US$2,475,000
2024-07-08 2024-07-08 PrS Proposed sale
1.2
MARC SCHEGERIN

Officer

Officer
43,936
55.80
US$2,451,629 		43,936 55.80 US$2,451,629
2024-07-08 2024-07-08 PrS Proposed sale
1.4
ROBERT FARRELL JR.

Officer

Officer
30,272
55.80
US$1,689,178 		30,272 55.80 US$1,689,178
2024-01-17 2024-01-16 S Sale
1.2
DeVaul William

General Counsel and Secretary

Officer
4,509 -16.4%
27.49
US$123,956 		4,509 -16.4% 27.49 US$123,956
2024-01-17 2024-01-16 S Sale
1.2
SCHEGERIN MARC

CFO and COO

Officer
6,041 -13.9%
27.49
US$166,071 		6,041 -13.9% 27.49 US$166,071
2024-01-17 2024-01-16 S Sale
1.4
Farrell Robert E Jr

SVP Finance and CAO

Officer
5,089 -12.7%
27.49
US$139,900 		5,089 -12.7% 27.49 US$139,900
2024-01-17 2024-01-16 S Sale
1.2
Tipirneni Praveen P.

CEO

Executive Director
13,923 -24.9%
27.49
US$382,753 		13,923 -24.9% 27.49 US$382,753
2024-01-17 2024-01-16 S Sale
1.6
Rogers Bruce

President

Officer
6,314 -4.3%
27.49
US$173,576 		6,314 -4.3% 27.49 US$173,576
2023-11-15 2023-11-13 B Purchase
3.4
Edwards Martin
Non-Executive Director
2,376 +inf%
20.54
US$48,803 		2,376 +inf% 20.54 US$48,803
2023-11-14 2023-11-13 B Purchase
3.9
SLATTERY JOSEPH P
Non-Executive Director
2,400 +36.0%
20.60
US$49,436 		2,400 +36.0% 20.60 US$49,436
2023-09-08 2023-09-07 PlS Planned sale
1.2
SCHEGERIN MARC

CFO and COO

Officer
13,309 -35.5%
54.92
US$730,885 		13,309 -35.5% 54.92 US$730,885
2023-09-08 2023-09-07 PlS Planned sale
1.2
SCHEGERIN MARC

CFO and COO

Officer
6,691 -15.2%
53.20
US$355,964 		6,691 -15.2% 53.20 US$355,964
2023-09-07 2023-09-07 PrS Proposed sale
1.2
MARC SCHEGERIN

Officer

Officer
20,000
54.34
US$1,086,848 		20,000 54.34 US$1,086,848
2023-08-03 2023-08-01 PlS Planned sale
1.2
Tipirneni Praveen P.

President and CEO

Executive Director
493 -3.4%
57.94
US$28,566 		493 -3.4% 57.94 US$28,566
2023-08-03 2023-08-01 PlS Planned sale
1.2
Tipirneni Praveen P.

President and CEO

Executive Director
1,638 -10.2%
57.42
US$94,052 		1,638 -10.2% 57.42 US$94,052
2023-08-03 2023-08-01 PlS Planned sale
1.2
Tipirneni Praveen P.

President and CEO

Executive Director
1,466 -8.4%
56.32
US$82,569 		1,466 -8.4% 56.32 US$82,569
2023-07-06 2023-07-03 PlS Planned sale
1.2
Tipirneni Praveen P.

President and CEO

Executive Director
3,597 -20.5%
57.04
US$205,178 		3,597 -20.5% 57.04 US$205,178
2023-06-14 2023-06-12 PlS Planned sale
1.2
Tipirneni Praveen P.

President and CEO

Executive Director
840 -5.7%
63.01
US$52,929 		840 -5.7% 63.01 US$52,929
2023-06-09 2023-06-07 PlS Planned sale
1.2
DeVaul William

General Counsel and Secretary

Officer
7,756 -36.8%
60.05
US$465,742 		7,756 -36.8% 60.05 US$465,742
2023-06-02 2023-06-01 PlS Planned sale
1.2
Tipirneni Praveen P.

President and CEO

Executive Director
1,609 -10.4%
57.64
US$92,737 		1,609 -10.4% 57.64 US$92,737
2023-06-02 2023-06-01 PlS Planned sale
1.2
Tipirneni Praveen P.

President and CEO

Executive Director
1,988 -11.3%
56.73
US$112,782 		1,988 -11.3% 56.73 US$112,782
2023-05-25 2023-05-24 PlS Planned sale
1.2
DeVaul William

General Counsel and Secretary

Officer
100 -0.5%
60.00
US$6,000 		100 -0.5% 60.00 US$6,000
2023-05-25 2023-05-23 PlS Planned sale
1.4
Farrell Robert E Jr

SVP Finance and CAO

Officer
10,000 -29.7%
60.00
US$600,000 		10,000 -29.7% 60.00 US$600,000
2023-05-25 2023-05-23 PlS Planned sale
1.2
DeVaul William

General Counsel and Secretary

Officer
3,802 -15.2%
60.03
US$228,236 		3,802 -15.2% 60.03 US$228,236
2023-05-23 2023-05-23 PrS Proposed sale
1.2
William DeVaul

affiliate
11,658
57.07
US$665,322 		11,658 57.07 US$665,322
2023-05-23 2023-05-23 PrS Proposed sale
1.4
ROBERT FARRELL

Officer

Officer
10,000
60.00
US$600,000 		10,000 60.00 US$600,000
2023-05-05 2023-05-03 PlS Planned sale
1.2
Tipirneni Praveen P.

President and CEO

Executive Director
3,597 -20.5%
51.11
US$183,857 		3,597 -20.5% 51.11 US$183,857
2023-05-04 2023-05-03 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
1,050,000 +61.1%
45.00
US$47,250,000 		1,050,000 +61.1% 45.00 US$47,250,000
2023-04-27 2023-04-25 PlS Planned sale
1.4
Farrell Robert E Jr

SVP Finance and CAO

Officer
10,000 -45.0%
54.71
US$547,100 		10,000 -45.0% 54.71 US$547,100
2023-04-27 2023-04-25 PlS Planned sale
1.2
SCHEGERIN MARC

CFO and COO

Officer
50,000 -67.4%
54.71
US$2,735,500 		50,000 -67.4% 54.71 US$2,735,500
2023-04-27 2023-04-25 PlS Planned sale
1.6
Rogers Bruce

President

Officer
30,000 -20.4%
53.40
US$1,602,129 		30,000 -20.4% 53.40 US$1,602,129
2023-04-27 2023-04-25 PlS Planned sale
1.2
Tipirneni Praveen P.

President and CEO

Executive Director
25,179 -64.4%
53.40
US$1,344,667 		25,179 -64.4% 53.40 US$1,344,667
2023-04-25 2023-04-25 PrS Proposed sale
1.2
Praveen Tiprineni

affiliate
35,970
54.85
US$1,972,955 		35,970 54.85 US$1,972,955
2023-04-25 2023-04-25 PrS Proposed sale
1.6
Bruce Rogers

Affiliate
30,000
54.85
US$1,645,500 		30,000 54.85 US$1,645,500
2023-04-25 2023-04-25 PrS Proposed sale
1.4
ROBERT FARRELL

Officer

Officer
10,000
54.71
US$547,100 		10,000 54.71 US$547,100
2023-04-25 2023-04-25 PrS Proposed sale
1.2
MARC SCHEGERIN

Officer

Officer
50,000
54.71
US$2,735,500 		50,000 54.71 US$2,735,500
2023-04-21 2023-04-20 PlS Planned sale
1.4
Farrell Robert E Jr

SVP Finance and CAO

Officer
10,000 -45.0%
45.00
US$450,000 		10,000 -45.0% 45.00 US$450,000
2023-04-20 2023-04-20 PrS Proposed sale
1.4
ROBERT FARRELL

Officer

Officer
10,000
45.00
US$450,000 		10,000 45.00 US$450,000
2023-04-19 2023-04-17 PlS Planned sale
1.4
Farrell Robert E Jr

SVP Finance and CAO

Officer
10,000 -81.8%
42.50
US$425,001 		10,000 -81.8% 42.50 US$425,001
2023-04-19 2023-04-17 PlS Planned sale
1.4
Farrell Robert E Jr

SVP Finance and CAO

Officer
10,000 -45.0%
40.00
US$400,000 		10,000 -45.0% 40.00 US$400,000
2023-04-19 2023-04-17 PlS Planned sale
1.6
Rogers Bruce

President

Officer
10,000 -7.9%
40.35
US$403,463 		10,000 -7.9% 40.35 US$403,463
2023-04-17 2023-04-17 PrS Proposed sale
1.4
ROBERT FARRELL

Officer

Officer
20,000
42.50
US$850,002 		20,000 42.50 US$850,002
2023-03-09 2023-03-07 PlS Planned sale
1.2
SCHEGERIN MARC

CFO and COO

Officer
50,000 -74.5%
45.00
US$2,250,050 		50,000 -74.5% 45.00 US$2,250,050
2023-02-16 2023-02-14 PlS Planned sale
1.6
Rogers Bruce

President

Officer
10,000 -7.9%
40.09
US$400,901 		10,000 -7.9% 40.09 US$400,901
2023-01-18 2023-01-14 S Sale
1.2
DeVaul William

General Counsel and Secretary

Officer
1,169 -4.7%
30.63
US$35,805 		1,169 -4.7% 30.63 US$35,805
2023-01-18 2023-01-14 S Sale
1.2
SCHEGERIN MARC

CFO and COO

Officer
1,670 -9.3%
30.63
US$51,150 		1,670 -9.3% 30.63 US$51,150
2023-01-18 2023-01-14 S Sale
1.6
Rogers Bruce

President

Officer
1,778 -1.5%
30.63
US$54,458 		1,778 -1.5% 30.63 US$54,458
2023-01-18 2023-01-14 S Sale
1.4
Farrell Robert E Jr

SVP Finance and CAO

Officer
1,248 -5.3%
30.63
US$38,224 		1,248 -5.3% 30.63 US$38,224
2023-01-18 2023-01-14 S Sale
1.2
Tipirneni Praveen P.

President and CEO

Executive Director
4,027 -24.1%
30.63
US$123,338 		4,027 -24.1% 30.63 US$123,338
2022-04-01 2022-04-01 PlS Planned sale
1.6
Rogers Bruce

Chief Scientific Officer

Officer
2,625 -2.5%
41.42
US$108,724 		2,625 -2.5% 41.42 US$108,724
2022-04-01 2022-04-01 PlS Planned sale
1.6
Rogers Bruce

Chief Scientific Officer

Officer
7,375 -6.5%
40.89
US$301,556 		7,375 -6.5% 40.89 US$301,556
2021-11-03 2021-11-01 PlS Planned sale
1.2
SCHEGERIN MARC

CFO and COO

Officer
5,477 -45.6%
60.00
US$328,620 		5,477 -45.6% 60.00 US$328,620
2021-10-28 2021-10-26 PlS Planned sale
1.2
SCHEGERIN MARC

CFO and COO

Officer
37 -0.6%
60.00
US$2,220 		37 -0.6% 60.00 US$2,220
2021-10-15 2021-10-15 PlS Planned sale
1.2
SCHEGERIN MARC

CFO and COO

Officer
3,338 -33.8%
60.00
US$200,280 		3,338 -33.8% 60.00 US$200,280
2021-10-15 2021-10-14 PlS Planned sale
1.2
SCHEGERIN MARC

CFO and COO

Officer
24,184 -78.7%
60.02
US$1,451,446 		24,184 -78.7% 60.02 US$1,451,446
2021-10-15 2021-10-13 PlS Planned sale
1.2
SCHEGERIN MARC

CFO and COO

Officer
1,964 -23.1%
60.00
US$117,845 		1,964 -23.1% 60.00 US$117,845
2021-09-17 2021-09-16 S Sale
3.3
Linde Peter

Chief Medical Officer

Officer
624 -5.2%
67.00
US$41,805 		624 -5.2% 67.00 US$41,805
2021-09-17 2021-09-16 S Sale
3.3
Linde Peter

Chief Medical Officer

Officer
3,276 -21.6%
66.48
US$217,803 		3,276 -21.6% 66.48 US$217,803
2021-09-17 2021-09-16 S Sale
3.3
Linde Peter

Chief Medical Officer

Officer
100 -0.7%
64.29
US$6,429 		100 -0.7% 64.29 US$6,429
2021-09-14 2021-09-13 PlS Planned sale
1.4
Farrell Robert E Jr

SVP Finance and CAO

Officer
3,049 -23.4%
65.01
US$198,202 		3,049 -23.4% 65.01 US$198,202
2021-09-13 2021-09-13 PlS Planned sale
1.6
Rogers Bruce

Chief Scientific Officer

Officer
1,721 -1.9%
65.00
US$111,873 		1,721 -1.9% 65.00 US$111,873
2021-09-14 2021-09-10 PlS Planned sale
1.4
Farrell Robert E Jr

SVP Finance and CAO

Officer
9,859 -43.0%
65.14
US$642,166 		9,859 -43.0% 65.14 US$642,166
2021-09-13 2021-09-10 PlS Planned sale
1.6
Rogers Bruce

Chief Scientific Officer

Officer
8,279 -8.4%
65.11
US$539,078 		8,279 -8.4% 65.11 US$539,078
2021-09-13 2021-09-09 PlS Planned sale
1.6
Rogers Bruce

Chief Scientific Officer

Officer
6,086 -6.3%
61.60
US$374,918 		6,086 -6.3% 61.60 US$374,918
2021-09-13 2021-09-09 PlS Planned sale
1.6
Rogers Bruce

Chief Scientific Officer

Officer
22,213 -18.8%
60.87
US$1,352,136 		22,213 -18.8% 60.87 US$1,352,136
2021-09-13 2021-09-09 PlS Planned sale
1.6
Rogers Bruce

Chief Scientific Officer

Officer
1,701 -1.4%
59.99
US$102,039 		1,701 -1.4% 59.99 US$102,039
2021-08-20 2021-08-20 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
11,511 +1.3%
56.80
US$653,839 		11,511 +1.3% 56.80 US$653,839
2021-08-20 2021-08-20 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
109 +0.0%
56.01
US$6,105 		109 +0.0% 56.01 US$6,105
Explore more

More insider trading research around Morphic Holding Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America